{
  "ptid_time": "137_S_0722_2012-08-31",
  "img_path": "/data/qiuhui/data/adni/images/137_S_0722/2012-08-31/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 64,956 mm³, 68.6% above the reference mean. With a Z-score of 1.64 (95.0th percentile), this represents moderate enlargement; whole brain volume measures 1,208,310 mm³, 11.9% above the reference mean. With a Z-score of 1.55 (93.9th percentile), this represents moderate enlargement; entorhinal cortex volume measures 2,688 mm³, 34.4% below the reference mean. With a Z-score of -2.34 (1.0th percentile), this represents significant atrophy; fusiform gyrus volume measures 20,785 mm³, 10.3% above the reference mean. With a Z-score of 0.88 (81.1th percentile), this represents normal volume ; middle temporal gyrus volume measures 22,301 mm³, 4.5% above the reference mean. With a Z-score of 0.41 (65.7th percentile), this represents normal volume . ",
  "text_data": "Age is 76.1 years. Gender is Male. Education: 12 years. MMSE: 25.0. MoCA: 20.0. Logical Memory: 13.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 0.93 SUVR (mild reduced). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The data shows significant atrophy in the entorhinal cortex (Z-score -2.34, 1st percentile), a region critical for memory and early Alzheimer's pathology, alongside moderate ventricular enlargement. The MMSE (25) and MoCA (20) scores indicate mild cognitive impairment, and the absence of APOE4 reduces genetic risk but does not rule out AD. The AV45 (amyloid PET) showing mild reduction suggests possible amyloid pathology.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer’s pathology given entorhinal atrophy and amyloid findings).  \n\n**Confidence:** **Medium** (clinical and imaging findings align with MCI, but amyloid burden is only mildly reduced, and APOE4-negative status adds some uncertainty).",
  "timestamp": "2025-07-26T16:16:52.017632"
}